Ignite Creation Date:
2024-05-06 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03642236
Status:
UNKNOWN
Last Update Posted:
2018-08-22
First Post:
2018-08-20
Brief Title:
Combination of BTK Inhibitor Overcomes Drug-resistance in RefractoryRelapsed FLT3 Mutant AML
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Brutons Tyrosine Kinase |
| FLT3-ITD Mutation |
| Acute Myeloid Leukemia |
Keywords: